rheumatic diseases/obesity

TECHNICAL FIELD The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient. More specifically, the present invention relates to (1) a compound of formula (I) ##STR00002##

TECHNICAL FIELD The present invention relates to a novel 1,3-dialkylurea derivative which has inhibitory effects on endopeptidase 24.11 and is useful as a therapeutic agent for cardiovascular diseases such as heart failure and hypertension, renal diseases such as renal failure, gastroenteric

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national stage of International Application No. PCT/JP2011/066766 filed Jul. 22, 2011. TECHNICAL FIELD The present invention relates to a novel fused heterocyclic compound having superior properties as a medicament, and use thereof.

CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2010/067383 filed Oct. 4, 2010, claiming priority based on Japanese Patent Application No. 2009-240008 filed Oct. 19, 2009, the contents of all of which are incorporated herein by

This application is a 371 of PCT/JP95/02236 filed Nov. 1, 1995, published as WO96/14293 May 17, 1996. TECHNICAL FIELD The present invention relates to novel 1,3-dialkylurea derivatives having a hydroxyl group which have inhibitory effects on endopeptidase 24.11 and are useful as therapeutic agents